Given its selectivity for BCL-2, an intrinsic mechanism of venetoclax resistance is due to increased AML blast dependency on the anti-apoptotic proteins, BCL-xL and MCL-1. The gene discussed is BCL2L1; the disease is acute myeloid leukemia.